A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

(2020) Heinz Reichmann et al.   Translational Neurodegeneration

Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe

(2019) Alison Cave et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease

(2019) Andreas–Antonios Roussakis et al.   Current Neurology and Neuroscience Reports

International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

(2018) Susan H. Fox et al.   MOVEMENT DISORDERS

Motor Complications of Dopaminergic Medications in Parkinson's Disease

(2017) Maria Freitas et al.   SEMINARS IN NEUROLOGY

Supramammillary glutamate neurons are a key node of the arousal system

(2017) Nigel P. Pedersen et al.   Nature Communications

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations

(2017) Anthony H. V. Schapira et al.   JAMA Neurology

Clinical Pharmacokinetics and Pharmacodynamics of Safinamide

(2016) Thomas Müller et al.   CLINICAL PHARMACOKINETICS

Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson’s Disease Fluctuating Patients: Post hoc Analysesof Studies 016 and SETTLE

(2016) Carlo Cattaneo et al.   Journal of Parkinsons Disease

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

(2013) Rupam Borgohain et al.   MOVEMENT DISORDERS

Early DEtection of wEaring off in Parkinson disease: The DEEP study

(2013) F. Stocchi et al.   PARKINSONISM & RELATED DISORDERS

Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson Disease

(2012) J. Michael Bostwick et al.   MAYO CLINIC PROCEEDINGS

Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease

(2011) Rebecca Stowe et al.   MOVEMENT DISORDERS

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

(2010) Lisa M. Shulman et al.   ARCHIVES OF NEUROLOGY

Levodopa: Past, Present, and Future

(2009) Robert A. Hauser   EUROPEAN NEUROLOGY

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

(2009) K Ray Chaudhuri et al.   LANCET NEUROLOGY

The clinical progression of Parkinson's disease

(2009) Werner Poewe et al.   PARKINSONISM & RELATED DISORDERS